What is CBG?
Cannabigerol (CBG) is a non-psychoactive cannabinoid that plays an important role in the biochemistry of the cannabis plant. CBG displays a multitude of potential health benefits including working as a neuroprotectant, having antioxidant properties, aiding with skin ailments as an antibacterial and antifungal agent, appetite stimulation, treatment of gastrointestinal disorders, inflammation reduction, shows promise in fighting cancer, and lowering intraocular pressure, which may benefit glaucoma patients.
How CBG Works
CBG is often referred to as the Mother of all Cannabinoids. CBG holds promise to be a key constituent in the overall medicinal benefits cannabis may provide. As cannabis research continues to rapidly evolve, CBG may emerge as one of the most therapeutically applicable and diverse cannabinoids to offer a wide range of possible remedies. CBG interacts with both the CB1 and CB2 receptors, acting as a possible inhibitor to the psychoactive effects of THC. CBG is also thought to boost anandamide, an endocannabinoid that naturally increases dopamine levels and responsible for regulating various health functions such as mood, sleep, and appetite. GABA uptake in the brain may be obstructed by CBG, making this cannabinoid a possible anti-anxiety agent and muscle relaxant. CBG may also block serotonin receptors, showing potential antidepressant traits.
“An Italian study published in the May 2013 edition of Biological Psychology suggests that cannabigerol (CBG) has strong anti-inflammatory properties and may benefit patients with inflammatory bowel disease (IBD). It is also useful in the treatment of glaucoma, as CBG can increase the fluid drainage from the eye and reduce the amount of pressure. Further, cannabigerol (CBG) has anti-depressant qualities and may inhibit tumor growth.”